Literature DB >> 5052390

Effects of DDAVP, a synthetic analogue of vasopressin, in patients with cranial diabetes insipidus.

K E Andersson, B Arner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5052390     DOI： 10.1111/j.0954-6820.1972.tb04772.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN： 0001-6101


× No keyword cloud information.
  18 in total

1.  A replicate study design for testing bioequivalence: a case study on two desmopressin nasal spray preparations.

Authors:  Christian Joukhadar; Barbara Schenk; Stefan T Kaehler; Christian J Kollenz; Peter Bauer; Markus Müller; Hans-Georg Eichler
Journal:  Eur J Clin Pharmacol       Date:  2003-10-17       Impact factor: 2.953

2.  Effect of intranasal histamine on nasal mucosal blood flow and the antidiuretic activity of desmopressin.

Authors:  L S Olanoff; C R Titus; M S Shea; R E Gibson; C D Brooks
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

3.  A vasopressin analogue in treatment of diabetes insipidus.

Authors:  R Kauli; Z Laron
Journal:  Arch Dis Child       Date:  1974-06       Impact factor: 3.791

4.  DDAVP in treatment of vasopressin-sensitive diabetes insipidus.

Authors:  M K Ward; T R Fraser
Journal:  Br Med J       Date:  1974-07-13

5.  Treatment with new synthetic analogue of vasopressin in diabetes insipidus.

Authors:  H Nash
Journal:  Arch Dis Child       Date:  1973-12       Impact factor: 3.791

6.  Diabetes insipidus--turning off the tap.

Authors: 
Journal:  Br Med J       Date:  1977-04-23

7.  Absolute bioavailability of an aqueous solution of 1-deamino-8-D-arginine vasopressin from different regions of the gastrointestinal tract in man.

Authors:  L d'Agay-Abensour; A Fjellestad-Paulsen; P Höglund; Y Ngô; O Paulsen; J C Rambaud
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Urinary concentration test with desmopressin.

Authors:  K Delin; M Aurell; J Ewald
Journal:  Br Med J       Date:  1978-03-25

9.  Inhibition of the diuretic action of glibenclamide by clofibrate, carbamazepine and 1-deamino-8-d-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.

Authors:  J P Radó; L Szende; J Marosi; E Juhos; I Sawinsky; J Takó
Journal:  Acta Diabetol Lat       Date:  1974 May-Jun

10.  Current place of vasopressin analogues in the treatment of septic shock.

Authors:  Christian Ertmer; Sebastian Rehberg; Andrea Morelli; Martin Westphal
Journal:  Curr Infect Dis Rep       Date:  2008-09       Impact factor: 3.725
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.